Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Renosis Inc. manages a company patent portfolio within the Chemistry & Materials technology area. The portfolio currently contains 2 pending office actions. These actions are spread across 2 distinct art units, indicating that the company's current filings cover a range of technical subjects within the chemistry field. For practitioners, this diversification across 2 art units means that the portfolio is subject to different sets of technical classification standards and examination guidelines.
The prosecution involves 2 distinct examiners, providing a diversity of perspectives on the company's applications. REDDY, KARUNA P is the busiest examiner for the portfolio, holding 1 busiest examiner pending action. This means that the workload is evenly divided, with REDDY, KARUNA P responsible for half of the 2 pending office actions. For practitioners, this distribution across 2 examiners and 2 art units requires a flexible strategy to address the different requirements and technical focuses of each prosecution track. This arrangement reduces the risk of the entire portfolio being impacted by the preferences of a single official.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REDDY, KARUNA P | 1 | 42.5% | +10.4% |
| PALENIK, JEFFREY T | 1 | 53.6% | +27.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18280649 | CROSSLINKED POLY (ALLYLAMINE) POLYMER PHARMACEUTICAL COMPOSITIONS | REDDY, KARUNA P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18280649 | CROSSLINKED POLY (ALLYLAMINE) POLYMER PHARMACEUTICAL COMPOSITIONS | REDDY, KARUNA P | — |
| 18238665 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | PALENIK, JEFFREY T | — |
| Art Unit | Apps |
|---|---|
| 1764 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18280649 | CROSSLINKED POLY (ALLYLAMINE) POLYMER PHARMACEUTICAL COMPOSITIONS | REDDY, KARUNA P | 1764 | §103§112 | Final Rejection | — | Pending | Sep 06, 2023 |
| 18238665 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | PALENIK, JEFFREY T | 1615 | §103DPOther | Final Rejection | — | Pending | Aug 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial